News
Researchers in South Korea have proposed a novel cancer immunotherapy approach ... in the journal Biomarker Research. B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly ...
Acute lymphocytic leukaemia (ALL) is a cancer of the blood and bone marrow, specifically affecting lymphocytes. The disease progresses rapidly and creates immature blood cells, rather than mature ...
A study has demonstrated the potential of a novel ligand-based CAR T-cell therapy for targeting CD7-positive T-cell malignancies, including T-cell acute lymphoblastic leukemia (T-ALL) and T-cell ...
Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...
Hosted on MSN1mon
Novel strategy for treating acute myelogenous leukemia identifiedA Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis ...
Sales of Amgen's Blincyto have grown slowly since it was first introduced a decade ago, but have started to gather momentum thanks to expanded use in acute lymphoblastic leukaemia (ALL), which ...
Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL). The US ...
as a potent selective target for treating acute myeloid leukemia (AML) as well as solid tumors. “Finding cell-surface targets that are specific to malignancies but spared on healthy tissue ...
“They had told us he has leukemia and that's what was wrong with him," she said. Axel was diagnosed with T-cell Acute Lymphoblastic Leukemia (T-ALL)a form so aggressive, doctors told the family ...
because I have so many wires sticking in to me. They thought I had some kind of cancer and it turned out I had Acute lymphoblastic leukaemia. It’s a type of blood cancer. Erm, and my dad didn’ ...
He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results